Drug profile · INN
levomilnacipran hydrochloride
LEVOMILNACIPRAN HYDROCHLORIDE
levomilnacipran hydrochloride (LEVOMILNACIPRAN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — levomilnacipran hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
levomilnacipran hydrochloride (LEVOMILNACIPRAN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is levomilnacipran hydrochloride?
levomilnacipran hydrochloride (LEVOMILNACIPRAN HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levomilnacipran hydrochloride?
LEVOMILNACIPRAN HYDROCHLORIDE is a marketed brand name for levomilnacipran hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levomilnacipran hydrochloride?
levomilnacipran hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.